Pharmacogenetics of asthma

被引：13

作者：

Hall, Ian P. ^{[1
]}

机构：

[1] Univ Nottingham Hosp, Div Therapeut & Mol Med, Nottingham NG7 2UH, England

来源：

CHEST | 2006年 / 130卷 / 06期

关键词：

asthma; beta; 2-agonists; pharmacogenetics;

D O I：

10.1378/chest.130.6.1873

中图分类号：

R4 [临床医学];

学科分类号：

1002 [临床医学]; 100602 [中西医结合临床];

摘要：

Pharmacogenetics offers the potential to optimize treatment for individual patients by using genetic information to improve efficacy or avoid side effects. While there are a number of examples in which the approach is already in routine clinical usage, exploitation of this approach in asthma is still under development. A number of examples of possible pharmacogenetic approaches that may prove of value in the management of asthma are discussed.

引用

收藏

页码：1873 / 1878

页数：6

相关论文

共 21 条

[1]

Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT1 antagonist, pranlukast, in Japanese patients with moderate asthma [J].

Asano, K ;

Shiomi, T ;

Hasegawa, N ;

Nakamura, H ;

Kudo, H ;

Matsuzaki, T ;

Hakuno, H ;

Fukunaga, K ;

Suzuki, Y ;

Kanazawa, M ;

Yamaguchi, K .

PHARMACOGENETICS, 2002, 12 (07) :565-570

[2]

Leukotriene C4 synthase polymorphisms and responsiveness to leukotriene antagonists in asthma [J].

Currie, GP ;

Lima, JJ ;

Sylvester, JE ;

Lee, DKC ;

Cockburn, WJR ;

Lipworth, BJ .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (04) :422-426

[3]

Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment [J].

Drazen, JM ;

Yandava, CN ;

Dubé, L ;

Szczerback, N ;

Hippensteel, R ;

Pillari, A ;

Israel, E ;

Schork, N ;

Silverman, ES ;

Katz, DA ;

Drajesk, J .

NATURE GENETICS, 1999, 22 (02) :168-170

[4]

Complex promoter and coding region β2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness [J].

Drysdale, CM ;

McGraw, DW ;

Stack, CB ;

Stephens, JC ;

Judson, RS ;

Nandabalan, K ;

Arnold, K ;

Ruano, G ;

Liggett, SB .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (19) :10483-10488

[5]

Pharmacogenetics of asthma [J].

Fenech, A ;

Hall, IP .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (01) :3-15

[6]

5-lipoxygenase polymorphism and in-vivo response to leukotriene receptor antagonists [J].

Fowler, SJ ;

Hall, IP ;

Wilson, AM ;

Wheatley, AP ;

Lipworth, BJ .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (03) :187-190

[7]

AMINO-TERMINAL POLYMORPHISMS OF THE HUMAN BETA(2)-ADRENERGIC RECEPTOR IMPART DISTINCT AGONIST-PROMOTED REGULATORY PROPERTIES [J].

GREEN, SA ;

TURKI, J ;

INNIS, M ;

LIGGETT, SB .

BIOCHEMISTRY, 1994, 33 (32) :9414-9419

[8]

The Ile164 β2-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to Gs [J].

Green, SA ;

Rathz, DA ;

Schuster, AJ ;

Liggett, SB .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 421 (03) :141-147

[9]

GREEN SA, 1993, J BIOL CHEM, V268, P23116

[10]

Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients [J].

Hakonarson, H ;

Bjornsdottir, US ;

Halapi, E ;

Bradfield, J ;

Zink, F ;

Mouy, M ;

Helgadottir, H ;

Gudmundsdottir, AS ;

Andrason, H ;

Adalsteinsdottir, AE ;

Kristiansson, K ;

Birkisson, I ;

Arnason, T ;

Andresdottir, M ;

Gislason, D ;

Gislason, T ;

Gulcher, JR ;

Stefansson, K .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (41) :14789-14794